Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,294 results that match your search.22,294 results
  • I was attending a professional meeting last month during which I was told by colleagues that Belgian people (applicants and patentees as well as patent attorneys) must be more attentive to their term list than other people in Europe in order to meet the deadlines. I must admit that the burden on the shoulders of people managing patent rights in Belgium is indeed high when acting before the Belgian Patent Office.
  • The Croatian Criminal Act entered into force on January 1 2013, replacing the Criminal Act of 1997. The new Act, besides other changes, substantially alters the enforcement process as it relates to acts which violate IP rights.
  • No biosimilar producers have made use of an accelerated US approval pathway introduced in 2010, and now the first case has found against a biosimilar for Enbrel. George Yu and Jason Harp explain where this leaves the industry
  • In October 2013, the Controller General of Patents rejected M/s BDR Pharmaceuticals International's application seeking a compulsory licence for Bristol Myers Squibb's patent covering the active pharmaceutical ingredient dasatinib, which is used to treat patients with chronic myeloid leukemia (CML). The application was rejected at a prima facie level due to the applicant's failure to make reasonable efforts to seek a voluntary licence.
  • Honigman Miller Schwartz and Cohn has grown its IP litigation group with three new partners. Jamal Edwards joins the firm's Detroit office. He is a former partner of Kirkland & Ellis, a former regional counsel for the IBM Corporation in Chicago and a former executive with Equifax.
  • The international coffee shop chain Starbucks has failed to stop a US coffee roasting company from selling a product called Charbucks. Starbucks sued the New Hampshire-based Wolfe's Borough Coffee, which trades as Black Bear Micro Roastery, more than a decade ago. In November the Second US Circuit Court of Appeals in New York backed a lower court that had declined to ban the defendant from selling Charbucks coffee.
  • One of the aims of this column is to be provocative, so here goes: there are good reasons to think that the continual and impressive growth in patent filing reported in the latest IP5 report will not continue, and that before long the number of applications will decline.
  • Universities such as Caltech are often held up as examples of good NPEs in discussions about intellectual property. What sorts of challenges do they face?
  • Members of the upper house in Australia’s parliament have called for the government to publish the final text of the trans-Pacific free trade deal before it is signed off by the cabinet
  • The Innovation Act was passed by the House of Representatives in a 325-91 vote yesterday, despite some heated opposition. It survived amendments that would have removed provisions moving to a loser-pays system and diluted the covered stay provisions